Coxsackie B-1 Antibody (Ab) is a specific immunological marker used in the detection of previous or ongoing infections caused by the Coxsackie B-1 virus, a member of the Enterovirus genus within the Picornaviridae family. This virus is known for its role in a variety of clinical syndromes, ranging from mild febrile illnesses to more severe conditions such as myocarditis, pericarditis, and aseptic meningitis. The presence of Coxsackie B-1 Ab, particularly IgM and IgG classes, in serum samples is indicative of the immune response triggered by the body against this pathogen. IgM antibodies usually suggest a recent acute infection, appearing early in the course of the disease and declining as the infection resolves. In contrast, IgG antibodies develop later and can persist for years, indicating past exposure and possibly conferring immunity. The detection of these antibodies is crucial for epidemiological surveillance, diagnosis, and understanding the immunopathology of Coxsackie B-1 virus infections. Advanced serological assays, including enzyme-linked immunosorbent assay (ELISA) and neutralization tests, are employed for accurate and sensitive detection of Coxsackie B-1 Ab, playing a significant role in clinical diagnosis and in differentiating this infection from other enteroviral diseases with similar clinical presentations.
Coxsackie B-1 Ab
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.